Tempest Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 29, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $70,000,000
Company Info
- Company Description
- Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
- Market
- Anti-tumor therapeutics
- Location
- San Francisco, CA, USA
- Coinvestors
- Eight Road Ventures, F-Prime Capital Partners, Foresite Capital, Lilly Asia Ventures, Quan Capital, Versant Ventures